Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Calvo

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Breast Cancer Research : BCR|January 17, 2013
Visualizing movement in the tumor microenvironment landscapeVeronica Calvo, Paraic A Kenny
International Journal of Cancer|June 5, 2013
TACE-dependent TGFα shedding drives triple-negative breast cancer cell invasionOrsi Giricz, Veronica Calvo, Esther A Peterson, et al.
Currents in Pharmacy Teaching & Learning|April 5, 2026
Health promotion, pharmaceutical training and public health: A scoping review on readiness and competencies in studies with students and professionalsVeronica Calvo Buzzi Leite, Sophia Ivantes Rodrigues, Leonardo Pestillo de Oliveira, et al.
BMC Cancer|May 31, 2015
Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatmentAlfred Adomako, Veronica Calvo, Noa Biran, et al.
Molecular and Cellular Biology|February 26, 2015
Epithelial Xbp1 is required for cellular proliferation and differentiation during mammary gland developmentDaisuke Hasegawa, Veronica Calvo, Alvaro Avivar-Valderas, et al.
Pharmaceutics|October 27, 2022
Optimization of a Novel Mandelamide-Derived Pyrrolopyrimidine Series of PERK InhibitorsMichael E Stokes, Matthew D Surman, Veronica Calvo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2023
PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase InhibitorsMichael E Stokes, Veronica Calvo, Sho Fujisawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2023
A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response-Dependent Survival of Quiescent Cancer CellsVeronica Calvo, Wei Zheng, Anna Adam-Artigues, et al.
Nature Cell Biology|January 24, 2017
Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironmentsGeorg Fluegen, Alvaro Avivar-Valderas, Yarong Wang, et al.
Bioorganic & Medicinal Chemistry Letters|April 25, 2021
Discovery of 2-amino-3-amido-5-aryl-pyridines as highly potent, orally bioavailable, and efficacious PERK kinase inhibitorsVeronica Calvo, David Surguladze, An-Hu Li, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Breast Cancer Research : BCR|January 17, 2013
Visualizing movement in the tumor microenvironment landscapeVeronica Calvo, Paraic A Kenny
International Journal of Cancer|June 5, 2013
TACE-dependent TGFα shedding drives triple-negative breast cancer cell invasionOrsi Giricz, Veronica Calvo, Esther A Peterson, et al.
Currents in Pharmacy Teaching & Learning|April 5, 2026
Health promotion, pharmaceutical training and public health: A scoping review on readiness and competencies in studies with students and professionalsVeronica Calvo Buzzi Leite, Sophia Ivantes Rodrigues, Leonardo Pestillo de Oliveira, et al.
BMC Cancer|May 31, 2015
Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatmentAlfred Adomako, Veronica Calvo, Noa Biran, et al.
Molecular and Cellular Biology|February 26, 2015
Epithelial Xbp1 is required for cellular proliferation and differentiation during mammary gland developmentDaisuke Hasegawa, Veronica Calvo, Alvaro Avivar-Valderas, et al.
Pharmaceutics|October 27, 2022
Optimization of a Novel Mandelamide-Derived Pyrrolopyrimidine Series of PERK InhibitorsMichael E Stokes, Matthew D Surman, Veronica Calvo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2023
PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase InhibitorsMichael E Stokes, Veronica Calvo, Sho Fujisawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2023
A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response-Dependent Survival of Quiescent Cancer CellsVeronica Calvo, Wei Zheng, Anna Adam-Artigues, et al.
Nature Cell Biology|January 24, 2017
Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironmentsGeorg Fluegen, Alvaro Avivar-Valderas, Yarong Wang, et al.
Bioorganic & Medicinal Chemistry Letters|April 25, 2021
Discovery of 2-amino-3-amido-5-aryl-pyridines as highly potent, orally bioavailable, and efficacious PERK kinase inhibitorsVeronica Calvo, David Surguladze, An-Hu Li, et al.
Pageof 2